Presentations
- Complex Cell Biology for Target Discovery and Validation
- The Path from Chemical Tool to Approvable Drug: An Integrated Approach to Drug Discovery
- Non-Clinical Safety: Considerations for Toxicology Studies
- Cardiac Safety Assays: A Focused Approach to De-Risking Drug Candidates for Potential Cardiovascular Liabilities; From Discovery/ Lead Optimization through GLP IND Studies
- ADME Considerations
Related Insights
- Outsourcing Early Drug Development
- Emerging Drug Discovery Alliance Models
- The Future of Drug Discovery? New Tech, A Focus On Human Biology, and Partnerships, Says Charles River
- Collaboration in Drug Discovery: An Interview with Dr. Swati Prasad of Charles River Laboratories
Have questions? Contact us to discuss how to get started on your next step.